Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

An Institutional Audit of Maximum Heart Dose in Patients Treated With Palliative Radiotherapy for Non-small Cell Lung Cancer

CARSTEN NIEDER and KRISTIAN S. IMINGEN
In Vivo March 2021, 35 (2) 955-958; DOI: https://doi.org/10.21873/invivo.12336
CARSTEN NIEDER
1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: carsten.nieder@nlsh.no
KRISTIAN S. IMINGEN
1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 35 no. 2 955-958
DOI 
https://doi.org/10.21873/invivo.12336
PubMed 
33622888

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received November 9, 2020
  • Revision received December 7, 2020
  • Accepted December 8, 2020
  • Published online February 23, 2021.

Copyright & Usage 
Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. CARSTEN NIEDER1,2⇑ and
  2. KRISTIAN S. IMINGEN1,2
  1. 1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
  2. 2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway
  1. Correspondence to: Carsten Nieder, Department of Oncology and Palliative Medicine, Nordland Hospital, 8092 Bodø, Norway. Tel.: +47 75578449, Fax: +47 75534975, e-mail: carsten.nieder{at}nlsh.no
View Full Text
PreviousNext
Back to top

In this issue

In Vivo: 35 (2)
In Vivo
Vol. 35, Issue 2
March-April 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An Institutional Audit of Maximum Heart Dose in Patients Treated With Palliative Radiotherapy for Non-small Cell Lung Cancer
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
An Institutional Audit of Maximum Heart Dose in Patients Treated With Palliative Radiotherapy for Non-small Cell Lung Cancer
CARSTEN NIEDER, KRISTIAN S. IMINGEN
In Vivo Mar 2021, 35 (2) 955-958; DOI: 10.21873/invivo.12336

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
An Institutional Audit of Maximum Heart Dose in Patients Treated With Palliative Radiotherapy for Non-small Cell Lung Cancer
CARSTEN NIEDER, KRISTIAN S. IMINGEN
In Vivo Mar 2021, 35 (2) 955-958; DOI: 10.21873/invivo.12336
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Three-month Prostate-specific Antigen Level After Androgen Deprivation Therapy Predicts Survival in Patients With Metastatic Castration-sensitive Prostate Cancer
  • A Finnish Version of RAND-36-Item Health Survey Versus Structured Interview 8 Years Postoperatively
  • Cytotoxic T-lymphocyte Antigen-4 (CTLA-4) Gene Polymorphism (rs3087243) Is Related to Risk and Survival in Patients With Colorectal Cancer
Show more Clinical Studies

Similar Articles

Keywords

  • Radiotherapy
  • Non-small cell lung cancer
  • palliative treatment
  • heart
  • dosimetric analysis
In Vivo

© 2021 In Vivo

Powered by HighWire